covaxin
Covaxin triggers higher antibody response in kids than adults: Bharat Biotech cites trial data-
Express News Service NEW DELHI: Days after the government announced that 15 to 17-year-olds in India will be eligible for ...
Covaxin alone for the 15-17; 39-week gap for COVID boosters-
Express News Service NEW DELHI: COvaxin is the only vaccine available for the 15-17 age group, vaccination for whom will ...
Only Covaxin for 15-18 year olds for now; precaution doses after 39 weeks of second Covid jab-
Express News Service NEW DELHI: The Centre on Monday announced that healthcare, frontline workers and those above 60 years with ...
For now, Covaxin likely to be only vaccine available for children of 15-18 years-
By PTI NEW DELHI: Bharat Biotech’s Covaxin is likely to be the only COVID-19 vaccine available, for now, for children ...
DGCI nod to Covaxin for use in children above 12 years with certain conditions-
By PTI NEW DELHI: The Drugs Controller General of India (DCGI) has granted emergency use authorisation to Bharat Biotech’s Covaxin ...
Booster likely for Covaxin recipients first, say sources –
Express News Service NEW DELHI: Covaxin recipients in India, not those who have taken Covishield, may become eligible for booster ...
Covishield production capacity 250-275 million doses a month, Covaxin 50-60 million: MoS Health
Both companies have achieved close to 90 percent of present production capacity, Minister of State for Health Bharati Pravin Pawar ...
Raebareli: Hundreds of vials of Covaxin were found in the garbage, CHC superintendent said – not ours – Raebareli: कोवैक्सीन की सैकड़ों शीशियां मिलीं कूड़े में, सीएचसी अधीक्षक ने कहा
रायबरेली. कोरोना वैक्सीन को लेकर एक सनसनीखेज मामला सोनिया गांधी के संसदीय क्षेत्र से सामने आया है. यहां कोरोना वैक्सीन ...
Covishield current monthly production capacity 250-275 million doses, Covaxin 50-60 mn doses: Government
Minister of State for Health Bharati Pravin Pawar said both companies have achieved close to 90 per cent of present ...
SEC recommendations on Covaxin emergency use authorisation for 2-18 age group being examined: Government
The CDSCO has also approved COVID-19 vaccine (ZyCoV-D) of Cadila Healthcare for restricted use in emergency situation in the age ...
